Publication | Closed Access

Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy

Metabolic SyndromeDiabetes ManagementMedicinePhysiologyHematologyDiabetesBlood Glucose MonitoringDifferent Glucose LevelsGliclazide TherapyDiabetes MellitusHyperglycemiaPharmacologyType IiHealth Sciences